| Literature DB >> 32019742 |
Lola Adekunle1, Rebecca Chen1, Lily Morrison1, Meghan Halley1, Victor Eng1, Yogi Hendlin2, Mackenzie R Wehner3,4, Mary-Margaret Chren5, Eleni Linos1.
Abstract
OBJECTIVE: To assess whether an association exists between financial links to the indoor tanning industry and conclusions of indoor tanning literature.Entities:
Mesh:
Year: 2020 PMID: 32019742 PMCID: PMC7190068 DOI: 10.1136/bmj.m7
Source DB: PubMed Journal: BMJ ISSN: 0959-8138
Fig 1PRISMA flow diagram
Categorization scheme of health themes
| Theme | Definition |
|---|---|
|
| |
| Phototherapy | Mentions any dermatologic skin disease that is treated with artificial ultraviolet |
| Photoprotection | Mentions how increased artificial ultraviolet tanning leads to epidermal changes or increased melanin that may give greater protection against ultraviolet |
| Source of vitamin D/bone health | Mentions that artificial ultraviolet leads to increased vitamin D and/or greater bone health |
| Physical attractiveness/cosmetic reasons | Mentions that artificial ultraviolet tanning improves appearance |
| Cancer prevention | Mentions that vitamin D has been associated with prevention of non-cutaneous cancer |
| Mood effects | Mentions that artificial ultraviolet tanning will lead to greater relaxation, stress reduction, or improved mood or self-esteem |
| Pain relief | Mentions that artificial ultraviolet tanning is able to alleviate pain |
| Lowers blood pressure | Mentions that artificial ultraviolet tanning helps to lower blood pressure |
| Endorphin generation | Mentions that endorphins are generated by use of artificial ultraviolet tanning |
|
| |
| Development of skin cancer | Mentions that artificial ultraviolet leads to development of skin cancer (NMSC or melanoma) |
| Accelerated aging | Mentions that artificial ultraviolet leads to increased skin wrinkles, leathery skin, age spots, or any other markers of aging skin |
| Addictive potential | Mentions use of artificial ultraviolet tanning being linked to behavior that may be addictive |
| Ocular damage | Mentions any type of harm to the eye due to artificial ultraviolet tanning (cataracts, melanoma) |
| DNA damage | Mentions artificial ultraviolet tanning causing damage to or molecular change in DNA |
| Other skin disease (SLE, pruritus, dryness, photodrug reaction) | Mentions artificial ultraviolet tanning causing skin reaction (allergic rash, pruritus (itching), dryness, or lupus-like rash) |
| Immunosuppression | Mentions how artificial ultraviolet can cause suppression of immune system |
| Hypervitaminosis D | Mentions how artificial ultraviolet can increase vitamin D concentrations above upper limit of normal |
| Cutaneous burn/erythema | Mentions artificial ultraviolet causing sunburns or increased erythema of skin causing pain |
NMSC=non-melanoma skin cancer; SLE=systemic lupus erythematosus.
Scale of tanning stance
| Score | Stance on indoor tanning |
|---|---|
| 1 | Strongly favors tanning |
| 2 | Favors tanning |
| 3 | Neutral/mixed |
| 4 | Critical of tanning |
| 5 | Strongly critical of tanning |
Categories of financial links to industry described in manuscript’s source of funding information and/or financial conflict of interest disclosures sections, with evidence of link
| Name of group, company, or individual | Example of link to industry |
|---|---|
|
| |
| Amber Leisure Ltd |
|
| Dan-Sun |
|
| KBL-Solarien AG |
|
| Nordic Solarium Ltd |
|
| Philips Lighting |
|
| Sperti Sunlamps (KBD, inc) |
|
| Summertan Netherlands |
|
| Wolff System Technology Corporation |
|
|
| |
| American Suntanning Association |
|
| Association of Sun Tanning Operators Ltd |
|
| Danish Sunbed Federation |
|
| European Sunlight Association |
|
| Foundation for General Light Therapy | |
| Indoor Tanning Association |
|
| Jörg Wolff Foundation |
|
| Sunlight, Nutrition, and Health Research Center (SUNARC) |
|
| Sunlight Research Forum |
|
| The Norwegian Tanning Association | - |
| Vitamin D Alliance |
|
| Vitamin D Council |
|
| Vitamin D Society |
|
| Ultraviolet (ultraviolet) Light Foundation |
|
|
| |
| Amgen |
|
| Anacor: acquired by Pfizer |
|
| Baxter |
|
| Dermapharm |
|
| DermTech International |
|
| Boots UK (Boots the Chemists) |
|
| Galderma |
|
| Genentech (acquired by Roche) |
|
| Immundiagnostik AG |
|
| Leo Pharmaceuticals |
|
| Otsuka |
|
| Pfizer Inc |
|
| Pharma-Vinci (acquired by Axellus) |
|
| Reckitt Benckiser |
|
| Roche Pharmaceuticals |
|
| Sanofi Aventis |
|
| Solgar Vitamins |
|
| Spirig Pharma (acquired by Galderma) |
|
| Stiefel/GlaxoSmithKline |
|
|
| |
| Dowdy JC | “RMS and JCD are paid consultants of Sperti Sunlamps on the vitamin D lamp project.” (Sayre, et al. 2007) |
| Farr PM | “Philips Lighting supplied the lamps used in the study and also contributed to nursing salary costs and patients’ travel expenses.” (Das, et al. 2002) |
| Grant WB | “WB Grant receives funding from the UV Foundation (McLean, VA, Australia) and the Vitamin D Society (Canada) and awaits funding from the European Sunlight Association.” (Grant, et al. 2007) |
| Holick MF | “MH serves as a consultant to the UV Foundation.” (Tangpricha, et al. 2004) |
| Moan J | Co-author on studies funded by SUNARC (Grant, et al. 2007; Grant, et al. 2010), supported by the Norwegian Tanning Association (Porojnicu, et al. 2008) and the Ultraviolet Foundation and European Sunlight Association (Moan, et al. 2009) |
| Porojnicu AC | “The sun bed used in the present study was borrowed from The Norwegian Tanning Association.” (Porojnicu, et al. 2008). Co-author on Grant, et al. 2007 (“WB Grant receives funding from the UV Foundation (McLean, VA, Australia) and the Vitamin D Society (Canada) and awaits funding from the European Sunlight Association.”) |
| Sayre RM | “RMS and JCD are paid consultants of Sperti Sunlamps on the vitamin D lamp project.” (Sayre, et al. 2007) |
| Wulf HC | “The authors are grateful to Royal Consul, Nykøbing Mors, Denmark, for lending us a sunbed during the study.” (Theiden, et al. 2008) |
Fig 2Number of indoor tanning articles by year between 1970 and 2018, using final analytic sample of articles
Descriptive analysis of articles by tanning stance, financial links, impact factor, and publication type. Values are numbers (percentages)
| Total (n=691) | Stance on indoor tanning | |||||
|---|---|---|---|---|---|---|
| 1: only asserts or describes health benefits (n=12; 1.7%) | 2: mostly asserts or describes health benefits (n=62; 9.0%) | 3: asserts or describes health risks and benefits equally (n=27; 3.9%) | 4: mostly asserts or describes health risks (n=150; 21.7%) | 5: only asserts or describes health risks (n=440; 63.7%) | ||
|
| ||||||
| Independent | 620 (89.7) | 5 (0.8) | 22 (3.5) | 22 (3.5) | 144 (23.2) | 427 (68.9) |
| Linked to indoor tanning industry (category A+B+D) | 50 (7.2) | 7 (14) | 32 (64) | 5 (10) | 3 (6) | 3 (6) |
| Tanning bed manufacturer (A) | 10 (14) | 0 (0) | 5 (50) | 3 (30) | 1 (10) | 1 (10) |
| Industry funded organization (B) | 22 (31) | 6 (27) | 14 (64) | 1 (5) | 1 (5) | 0 (0) |
| Pharmaceutical company only (C) | 21 (30) | 0 (0) | 8 (38) | 0 (0) | 3 (14) | 10 (48) |
| Author only (D) | 18 (25) | 1 (6) | 13 (72) | 1 (6) | 1 (6) | 2 (11) |
|
| ||||||
| 0-5.00 | 368 (53.3) | 8 (2) | 45 (12) | 9 (2) | 78 (21) | 228 (62) |
| 5.01-10 | 202 (29.2) | 1 (1) | 11 (5) | 15 (7) | 43 (21) | 132 (65) |
| ≥10.01 | 59 (8.5) | 2 (3) | 2 (3) | 0 (0) | 16 (27) | 39 (66) |
| Unknown | 62 (9.0) | 1 (2) | 4 (6) | 3 (5) | 13 (21) | 41 (66) |
|
| ||||||
| Empiric research: | ||||||
| Original article | 300 (43.4) | 5 (2) | 31 (10) | 15 (5) | 76 (23) | 173 (58) |
| Research letter | 46 (6.7) | 0 (0) | 1 (2) | 0 (0) | 6 (13) | 39 (85) |
| Systematic review, meta-analysis | 11 (1.6) | 0 (0) | 1 (9) | 0 (0) | 0 (0) | 10 (91) |
| Total | 357 (52) | 5 (1) | 33 (9) | 15 (4) | 82 (23) | 222 (62) |
| Non-empiric articles: | ||||||
| Review | 121 (17.5) | 2 (2) | 14 (12) | 4 (3) | 34 (28) | 67 (55) |
| Editorial, commentary, viewpoint, perspective | 121 (17.5) | 0 (0) | 4 (3) | 4 (3) | 26 (21) | 87 (72) |
| Case report (includes clinical challenge) | 40 (5.8) | 3 (8) | 4 (10) | 1 (3) | 3 (8) | 29 (73) |
| Letters (to the editor) | 30 (4.3) | 1 (3) | 6 (20) | 2 (7) | 3 (10) | 18 (60) |
| Comment/response | 22 (3.2) | 1 (5) | 1 (5) | 1 (5) | 2 (9) | 17 (77) |
| Total | 334 (48.3) | 7 (2) | 29 (9) | 12 (4) | 68 (20) | 218 (65) |
|
| ||||||
| Before 1990 | 44 (6.4) | 2 (5) | 10 (23) | 2 (5) | 8 (18) | 22 (50) |
| 1990 or after | 647 (93.6) | 10 (1.5) | 52 (8.0) | 25 (3.9) | 142 (21.9) | 418 (64.6) |
Fig 3Proportion of published articles on indoor tanning according to financial links and stance on indoor tanning
Fig 4Forest plot including primary, secondary, and sensitivity analyses. Relative risks of industry funded paper being in favor of tanning (relative to non-industry funded paper) with 95% confidence intervals